We are live on ! Find out more
RIM

Ranger Investment Management Portfolio holdings

AUM $1.38B
1-Year Est. Return 24.55%
This Fund
S&P 500
This Quarter Est. Return
-17.35%
1 Year Est. Return
+24.55%
3 Year Est. Return
+71.57%
5 Year Est. Return
+99.08%
10 Year Est. Return
+783.32%
AUM
$1.23B
AUM Growth
-$289M
Cap. Flow
+$6.83M
Cap. Flow %
0.56%
Top 10 Hldgs %
30.79%
Holding
138
New
29
Increased
46
Reduced
32
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 21.91%
2 Industrials 20.72%
3 Healthcare 20.62%
4 Consumer Staples 9.7%
5 Consumer Discretionary 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIME
26
DELISTED
Mimecast Limited
MIME
$20.9M 1.7%
+621,227
New +$21.7M
HSKA
27
DELISTED
Heska Corp
HSKA
$19.8M 1.61%
229,760
+143,359
+166% +$14.1M
TCMD icon
28
Tactile Systems Technology
TCMD
$665M
$18.9M 1.54%
415,473
+357,988
+623% +$20.7M
CCMP
29
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$18.7M 1.53%
196,270
-3,077
-2% -$302K
SLAB icon
30
Silicon Laboratories
SLAB
$7.23B
$18M 1.47%
228,187
+99,927
+78% +$8.31M
NEO icon
31
NeoGenomics
NEO
$2.13B
$18M 1.47%
1,425,720
+203,085
+17% +$3.03M
LMAT icon
32
LeMaitre Vascular
LMAT
$1.86B
$17.3M 1.41%
732,380
+9,688
+1% +$265K
OXM icon
33
Oxford Industries
OXM
$552M
$16.9M 1.38%
+238,534
New +$19.3M
NEOG icon
34
Neogen
NEOG
$2.5B
$16.8M 1.37%
590,068
+176,416
+43% +$5.52M
BOX icon
35
Box
BOX
$4.6B
$15.9M 1.3%
941,869
-93,471
-9% -$1.72M
SITE icon
36
SiteOne Landscape Supply
SITE
$4.53B
$15.2M 1.24%
274,493
-233,241
-46% -$14.6M
KNL
37
DELISTED
Knoll, Inc.
KNL
$15M 1.22%
910,728
-885,977
-49% -$17.3M
SUPN icon
38
Supernus Pharmaceuticals
SUPN
$2.77B
$13.9M 1.13%
418,033
-182,431
-30% -$7.84M
MBUU icon
39
Malibu Boats
MBUU
$567M
$13.1M 1.07%
375,983
-169,776
-31% -$7.46M
LTXB
40
DELISTED
LegacyTexas Financial Group Inc
LTXB
$12.9M 1.05%
402,434
-197,186
-33% -$7.54M
IDTI
41
DELISTED
Integrated Device Technology I
IDTI
$12.9M 1.05%
265,524
-333,568
-56% -$15.8M
BLD
42
DELISTED
TopBuild
BLD
$12.5M 1.02%
278,254
-129,191
-32% -$6.28M
AXON
43
Axon Enterprise
AXON
$46.4B
$11.6M 0.95%
+264,850
New +$13.7M
MEDP icon
44
Medpace
MEDP
$16.5B
$11.1M 0.9%
+209,589
New +$11.5M
TREE icon
45
LendingTree
TREE
$451M
$11M 0.9%
50,024
-7,591
-13% -$1.72M
CHGG icon
46
Chegg
CHGG
$102M
$10.9M 0.89%
+385,297
New +$10.4M
CVCO icon
47
Cavco Industries
CVCO
$4.55B
$10.1M 0.82%
77,467
-21,893
-22% -$3.96M
NSSC icon
48
Napco Security Technologies
NSSC
$1.48B
$8.31M 0.68%
1,055,556
+117,326
+13% +$896K
CPE
49
DELISTED
Callon Petroleum Company
CPE
$8.1M 0.66%
124,844
-1,932
-2% -$186K
SLP icon
50
Simulations Plus
SLP
$371M
$7.56M 0.62%
379,944
+42,799
+13% +$845K

Similar funds

Ranger Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Ranger Investment Management held 138 positions worth $1.23B, down 19% from $1.52B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ranger Investment Management's Q4 2018 filing shows 29 new, 46 increased, 32 reduced and 10 closed positions. Its largest new stake was EVO Payments, Inc. Class A Common Stock: 971,969 shares worth $24M. The largest sale was Sonic Corp, an estimated $30.7M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.

  • Ranger Investment Management's largest Q4 2018 buy was EVO Payments, Inc. Class A Common Stock: 971,969 shares worth $24M.
  • Ranger Investment Management added most to Tactile Systems Technology in Q4 2018, an estimated $20.7M increase.
  • Ranger Investment Management's biggest Q4 2018 reduction was Knoll, Inc., cutting an estimated $17.3M.
  • Ranger Investment Management fully exited Sonic Corp in Q4 2018, selling an estimated $30.7M.
  • Ranger Investment Management's ten largest holdings make up 31% of its $1.23B portfolio in Q4 2018.
  • Ranger Investment Management opened 29 new positions and closed 10 in Q4 2018.
  • Ranger Investment Management's portfolio value fell 19% quarter-over-quarter to $1.23B.

Based on Ranger Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.